NT-proBNP and D-Dimer in acute decompensated heart failure: assessment of diagnostic accuracy and correlation with

Nandini Nair1, Shengping Yang1, Caroline Marzbani1

  • 1Division of Cardiology, Department of Medicine, TTUHSC, Lubbock, TX, USA.

Acta Cardiologica
|January 25, 2022
PubMed

Insights

In acute decompensated heart failure, NT-proBNP and D-Dimer show comparable diagnostic accuracy. D-Dimer levels correlate with NT-proBNP but not echocardiographic findings, suggesting unique mechanisms.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Heart Failure Pathophysiology

Background:

  • Coagulation and inflammation are altered in heart failure.
  • Biomarkers like NT-proBNP and D-Dimer are crucial for diagnosis and prognosis.
  • Understanding their roles in acute decompensated heart failure (ADHF) is essential.

Purpose of the Study:

  • To compare the diagnostic accuracy of NT-proBNP and D-Dimer in ADHF.
  • To assess the correlation between these biomarkers and echocardiographic parameters.
  • To elucidate the pathophysiological significance of D-Dimer in ADHF.

Main Methods:

  • Retrospective cross-sectional study of 162 ADHF patients and 253 controls.
  • Exclusion of pulmonary embolism using CT or VQ scans.
  • Correlation analysis of NT-proBNP and D-Dimer with echocardiographic data.

Main Results:

  • NT-proBNP and D-Dimer demonstrated high diagnostic accuracy (AUCs 0.963 and 0.928).
  • A combination of both biomarkers showed a slightly higher AUC (0.982) but not statistically significant compared to D-Dimer alone.
  • NT-proBNP correlated significantly with echocardiographic parameters, while D-Dimer did not.

Conclusions:

  • NT-proBNP and D-Dimer exhibit comparable diagnostic utility in ADHF.
  • D-Dimer's lack of correlation with echocardiographic findings suggests independent mechanisms in ADHF.
  • Further research is needed to clarify the role of D-Dimer in heart failure pathophysiology.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
38
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
102
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
250
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
132
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
388
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
52